-
1 Comment
CLSA Premium Limited is currently in a long term downtrend where the price is trading 0.1% below its 200 day moving average.
From a valuation standpoint, the stock is 404.2% more expensive than other stocks from the Financial Services sector with a price to sales ratio of 74.7.
CLSA Premium Limited's total revenue sank by 27.1% to $2M since the same quarter in the previous year.
Its net income has increased by 51.0% to $-50M since the same quarter in the previous year.
Finally, its free cash flow grew by 222.6% to $19M since the same quarter in the previous year.
Based on the above factors, CLSA Premium Limited gets an overall score of 2/5.
ISIN | KYG2R50B1046 |
---|---|
Exchange | HK |
Sector | Financial Services |
Industry | Capital Markets |
CurrencyCode | HKD |
Market Cap | 874M |
---|---|
PE Ratio | 43.0 |
Target Price | None |
Beta | 1.71 |
Dividend Yield | None |
CLSA Premium Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. It operates through Healthcare Products and Margin Dealing segments. The company also offers leveraged foreign exchange trading, commodity and index trading, and other trading services. The company was formerly known as KVB Kunlun Financial Group Limited and changed its name to CLSA Premium Limited in November 2019. CLSA Premium Limited was incorporated in 2010 and is headquartered in Wan Chai, Hong Kong. CLSA Premium Limited is a subsidiary of CITIC Securities International Company Limited. As of April 1, 2025, CLSA Premium Limited operates as a subsidiary of Beijing Tong Ren Tang (Cayman) Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6877.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025